Rapid complexing of oxoacylglycerols with amino acids, peptides and aminophospholipids.
We prepared model Schiff bases from 2-[9-oxo]nonanoyl glycerol (2-MAG-ALD) and various amino compounds. 2-MAG-ALD was obtained by pancreatic lipase hydrolysis of trioleoyl glycerol and reductive ozonolysis of the resulting 2-monooleoyl glycerol. The reaction products were purified by thin-layer chromatography. Schiff bases were synthesized in greater than 50% yield by reacting 2-MAG-ALD with twofold molar excess of valine, Nalpha-acetyl-L-lysine methyl ester and the tripeptides glycyl-glycyl-glycine, glycyl-glycyl-histidine, and glycyl-histidyl-lysine in aqueous methanol and with 1-palmitoyl-2-stearoyl glycerophosphoethanolamine (PE) in chloroform/methanol for 16 h at room temperature. Prior to analysis the bases were reduced with sodium cyanoborohydride in methanol for 30 min at 4 degrees C. Reaction products were analyzed by high-performance liquid chromatography/electrospray ionization/mass spectrometry (HPLC/ESI/MS). Reduced Schiff bases of 2-MAG-ALD with PE and amino acids were analyzed by normal-phase HPLC/ESI/MS and those with peptides by reversed-phase HPLC/ESI/MS. Single adducts were obtained in all cases and both the alpha-amino group of valine and the epsilon-amino group of Nalpha-acetyl-L-lysine methyl ester were reactive. Molecular ions of reaction products were the only detected ions in the negative ionization mode, whereas in the positive ion mode sodiated molecular ions were also detected. The present study suggests that 2-MAG-ALD may form Schiff base adducts with amino compounds in other aqueous media, such as the intestinal lumen and in the hydrophobic environment of cell membranes.
Kurvinen
J P
JP
Banting and Best Department of Medical Research, University of Toronto, Ontario, Canada.
Kuksis
A
A
Ravandi
A
A
Sjövall
O
O
Kallio
H
H
D000596:Amino Acids / Q000737:chemistry* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004042:Dietary Fats, Unsaturated / Q000032:analysis* / Q000378:metabolism / Q000493:pharmacokinetics; D005990:Glycerol / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000378:metabolism; D013058:Mass Spectrometry; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000737:chemistry; D010743:Phospholipids / Q000737:chemistry* / Q000378:metabolism; D012545:Schiff Bases / Q000737:chemistry
C119628:2-(9-oxo)nonanoyl glycerol; D000596:Amino Acids; D004042:Dietary Fats, Unsaturated; D010455:Peptides; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D012545:Schiff Bases; D005990:Glycerol